COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia

COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia

Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against...

Full description

Bibliographic Details
Main Authors: Awan K. Rahman, Adam G. Purdy, Peter T. Ender
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2020/8822753
id doaj-7ebe40e2d0c84fd0a9ffddc8d54fb2b7
record_format Article
spelling doaj-7ebe40e2d0c84fd0a9ffddc8d54fb2b72020-11-25T04:03:49ZengHindawi LimitedCase Reports in Infectious Diseases2090-66252090-66332020-01-01202010.1155/2020/88227538822753COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 PneumoniaAwan K. Rahman0Adam G. Purdy1Peter T. Ender2Section of Pulmonary and Critical Care, St. Luke’s University Health Network, Bethlehem, PA, USASection of Pulmonary and Critical Care, St. Luke’s University Health Network, Bethlehem, PA, USASection of Infectious Diseases, St. Luke’s University Health Network, Bethlehem, PA, USAHydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against the use of hydroxychloroquine as a preventative or therapeutic option for COVID-19 pneumonia.http://dx.doi.org/10.1155/2020/8822753
collection DOAJ
language English
format Article
sources DOAJ
author Awan K. Rahman
Adam G. Purdy
Peter T. Ender
spellingShingle Awan K. Rahman
Adam G. Purdy
Peter T. Ender
COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
Case Reports in Infectious Diseases
author_facet Awan K. Rahman
Adam G. Purdy
Peter T. Ender
author_sort Awan K. Rahman
title COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title_short COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title_full COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title_fullStr COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title_full_unstemmed COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title_sort covid-19 pneumonia in patients on chronic hydroxychloroquine therapy: three cases of covid-19 pneumonia
publisher Hindawi Limited
series Case Reports in Infectious Diseases
issn 2090-6625
2090-6633
publishDate 2020-01-01
description Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against the use of hydroxychloroquine as a preventative or therapeutic option for COVID-19 pneumonia.
url http://dx.doi.org/10.1155/2020/8822753
work_keys_str_mv AT awankrahman covid19pneumoniainpatientsonchronichydroxychloroquinetherapythreecasesofcovid19pneumonia
AT adamgpurdy covid19pneumoniainpatientsonchronichydroxychloroquinetherapythreecasesofcovid19pneumonia
AT petertender covid19pneumoniainpatientsonchronichydroxychloroquinetherapythreecasesofcovid19pneumonia
_version_ 1715057052452126720

Similar Items